Company news

Imunon, Inc. news in 2025

Imunon, Inc.'s news releases, calls and decks from 2025, newest first.

View company

IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer

February 19, 2025

IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer

February 9, 2025

← Newer news releases

Calls in 2025

Decks in 2025